Pérez-Manauta J

Language: Spanish
References: 16
Page: 305-308
PDF size: 33.38 Kb.

Text Extraction

No abstract

REFERENCES

1. Hanauer S. New lessons: classic treatment, expanding options in ulcerative colitis. Colorectal Dis 2006; 8 (Suppl): 20-4.

2. Travis S. Review articles: induction therapy for patients with active ulcerative colitis. Aliment Pharmacol Ther 2006; 24: 10-6.

3. Haghighi DB, Lashner BA. Left-sided ulcerative colitis. Gastroenterol Clin N Am 2004; 33: 271-84.

4. Feagan B. Medical Management of Ulcerative Colitis in 2006: What’s on the Horizon? Am J Gastroenterol 2007; 102: S7-S13.

5. Hanauer S. Medical Therapy for Ulcerative Colitis 2004. Gastroenterol 2004; 126: 1582-92.

6. Kornbluth A, Sachar D. Practice Guidelines. Ulcerative Colitis Practice Guidelines in Adults (Update): American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol 2004.

7. Qureshi A, Cohen R. Mesalamine delivery system: do they really make much difference? Advanced Drug Delivery Reviews 2005; 57: 281-302.

8. Carter MJ, Lobo AJ, Travis SPL. Guidelines for the management of inflammatory bowel disease in adult. Gut 2006; 53: 1-16.

9. Hanauer S, Sandborn W, Kornbluth A, Katz S, Safdi M, Woogen S, et al. Delayed- Release Oral Mesalamine at 4.8 g/day (800 mg tablet) for the treatment of Moderately Active Ulcerative Colitis: The ASCEND II Trial. Am J Gastroenterol 2005; 100: 2478-85.

10. Danese S, Semerro S, Papa A, Roberto I, Scaldeferri F, Fedeli G, et al. Extraintestinal manifestations in inflammatory bowel disease. World J Gastroenterol 2005; 11: 7227-36.

11. Meuwissen S, Crusius B, Peña AS, Dekker-Saeys AJ, Dijkmans C. Spondyloarthropathy and Idiopathic Inflammatory Bowel Diseases. Inflamm Bowel Dis 1997; 3: 25-37.

12. Holden W, Orchard T, Wordsworth P. Artritis enteropática. Rheumatic Dis Clin N Am 2003; 5: 443-57.

13. Storch I, Sachar D, Katz S. Pulmonary Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis 2003; 9: 104-15.

14. Lebwohl M, Lebwohl O. Cutaneous Manifestations of Inflammatory Bowel Disease. Infl Bowel Dis 1998; 4: 142-8.

15. Mintz R, Feller ER, Bahr RL, Shah SA. Ocular Manifestations of Inflammatory Bowel Disease. Inflamm Bowel Dis 2004; 10: 135-9.

16. Barrie A, Plevy S. Treatment of Inmmune-Mediated Extraintestinal Manifestations of Inflammatory Bowel Disease with Infliximab. Gastroenterol Clin N Am 2006; 35: 883-93.